Tu sei qui

Curriculum Vitae

Expand | Collapse

Panagiotis Kourounakis

Professor Emeritus (Retired), School of Pharmacy

Personal Information

- 2310997621
panoskur@pharm.auth.gr

Course Work

Courses of Winter semester of 2017–18 academic year

	METAPTYCΗIAKO TMĪMATOS FARMAKEUTIKĪS
ΑΦ0003	ADVANCED TOPICS IN THE METABOLISM OF XENOBIOTICS
ΑΦ0006	ADVANCED MEDICINAL CHEMISTRY

Publications

2011

Doulgkeris C. M, Siskou I. C, Xanthopoulou N, Lagouri V, Kravaritou C, Eleftheriou P, Kourounakis P. N, Rekka E. A (2011). Compounds against inflammation and oxidative insult as potential agents for neurodegenerative disorders. Medicinal Chemistry Research. p.1-12.

2010

Rekka E. A, Kourounakis P. N (2010). Medicinal chemistry of 2,2,4-substituted morpholines. Current medicinal chemistry. vol.17 no.29 p.3422-3430.

2009

Tsiakitzis K. C, Rekka E. A, Kourounakis A. P, Kourounakis P. N (2009). Novel compounds designed as antistress agents. J Med Chem. vol.52 no.22 p.7315-7318.

2008

Kourounakis A. P, Charitos C, Rekka E. A, Kourounakis P. N (2008). Lipid –lowering (hetero) aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity. J Med Chem. EA. 4). vol.51 no.18 p.5861-5865.
Tavridou A, Kaklamanis L, Papalois A, Kourounakis A. P, Rekka E. A, Kourounakis P. N, Charalambous A, Manolopoulos V. G (2008). Antiatherosclerotic properties of EP2302, a novel squalene synthase inhibitor, in the cholesterol-fed rabbit. J Cardiovasc Pharmacol. ΕΑ. 1). vol.51 no.6 p.573-580.

2007

Kourounakis P. N, Rekka E. A, Galanakis D, Doulgeris C, Siskou I, Tsiakitzis K, Kourounakis A. P, Gavalas A (2007). Structural modification of non steroidal anti-inflammatory drugs can lead to the discovery of better agents against diseases of modern societies. Epitheorese Klinikes Farmakologias kai Farmakokinetikes. vol.25 no.1 p.67-68.
Siskou I. C, Rekka E. A, Kourounakis A. P, Chrysselis M. C, Tsiakitzis K, Kourounakis P. N (2007). Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties. Bioorg & Med Chem. vol.15 no.2 p.951-961.
Tavridou A, Kaklamanis L, Papalois A, Kourounakis A. P, Rekka E. A, Kourounakis P. N, Charalambous A, Manolopoulos V. G (2007). EP2306 [2-(4-biphenyl) -4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit. J Pharmacol ExpTher. ΕΑ. 5). vol.323 no.3 p.794-804.

2006

Doulgkeris C. M, Galanakis D, Kourounakis A. P, Tsiakitzis K. C, Gavalas A. M, Eleftheriou P. T, Victoratos P, Rekka E. A, Kourounakis P. N (2006). Synthesis and pharmacochemical study of novel polyfunctional molecules combining anti-inflammatory, antioxidant, and hypocholesterolemic properties. Bioorganic and Medicinal Chemistry Letters. vol.16 no.4 p.825-829.
Tavridou A, Kaklamanis L, Megaritis G, Kourounakis A. P, Papalois A, Roukounas D, Rekka E. A, Kourounakis P. N, Charalambous A, Manolopoulos V. G (2006). Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis. Eur J Pharmacol. ΕΑ. 17). vol.535 no.1-3 p.34-42.
Ziakas G. N, Rekka E. A, Gavalas A. M, Eleftheriou P. T, Kourounakis P. N (2006). New analogues of butylated hydroxytoluene as anti-inflammatory and antioxidant agents. Bioorg & Med Chem. vol.14 no.16 p.5616-5624.

2005

Rekka E. A, Kourounakis A. P, Avramidis N, Kourounakis P. N (2005). Effect of some biologically interesting substituted tetrahydro-1,4-oxazines on drug metabolising enzymes and on inflammation. Curr Drug Metab. ΕΑ. 0). vol.6 no.5 p.481-485.
Tsiakitzis K, Kourounakis A. P, Tani E, Rekka E. A, Kourounakis P. N (2005). Stress and active oxygen species--effect of alpha-tocopherol on stress response. Arch Pharm. ΕΑ. 2). vol.338 no.7 p.315-321.
Ziakas G. N, Rekka E. A, Gavalas A. M, Eleftheriou P. T, Tsiakitzis K. C, Kourounakis P. N (2005). Nitric oxide releasing derivatives of tolfenamic acid with anti-inflammatory activity and safe gastrointestinal profile. Bioorg & Med Chem. vol.13 no.23 p.6485-6492.

2003

Xanthopoulou N. J, Kourounakis A. P, Spyroudis S, Kourounakis P. N (2003). Synthesis and activity on free radical processes and inflammation of 9,10-dihydro-5,8-dimethoxy-triptycene-quinones. European journal of medicinal chemistry. vol.38 no.6 p.621-626.

2002

Kourounakis A. P, Victoratos P, Peroulis N, Stefanou Nikolaos, Yiangou Minas, Chatzipetrou-Kourounaki Lygeri, Kourounakis Panagiotis (2002). Experimental hyperlipidemia and the effect of NSAIDs. Experimental and molecular pathology. vol.73 no.2 p.135-138.

1998

Gavalas A. M, Hadjipetrou L, Kourounakis P. N (1998). Synthesis of novel derivatives of aroylaminoalcohols and 3-amino-substituted 1-phenylpropanols with potential anti-inflammatory and immunomodulating activities. Journal of Pharmacy and Pharmacology. vol.50 no.6 p.583-591.

1994

Gavalas Antonis, Victoratos P, Yiangou Minas, Chatzipetrou-Kourounaki Lygeri, Rekka Eleni, Kourounakis Panagiotis (1994). The anti-inflammatory effects of opioids: relevance to rheumatoid arthritis. International Journal of Neuroscience. vol.74 no.1-4 p.259-264.

1992

Hadjipetrou-Kourounakis L, Rekka E, Kourounakis P (1992). Suppression of adjuvant induced disease (AID) by anovel analgesic-opioid agonist which also possesses antioxidant activity. Annals New York Academy of Sciences. vol.650 p.19-24.

1991

Chatzipetrou-Kourounaki Lygeri, Gavalas Antonis, Karagouni E. E, Litina D, Kourounakis Panagiotis (1991). Anti-inflammatory and immunomodulating effects of the novel agent gamma-(2-aminoethylamino)-2-butyrothienone. 2nd communication: inhibitory effect on rat adjuvant induced disease. Arzneimittel Forschung - Drug Research. vol.41(I) p.537-541.
Hadjipavlou-Litina Dimitra, Rekka E, Chatzipetrou-Kourounaki Lygeri, Kourounakis Panagiotis (1991). Synthesis and biological studies of some novel antiinflammatory aryl-hydroxy-amino-ketones. European journal of medicinal chemistry. vol.26 p.85-90.
Kourounakis P, Rekka E, Hadjipetrou-Kourounakis L (1991). Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation. Pharmazie. vol.46 p.727-729.

1990

Rekka E, Kourounakis L, Kourounakis P (1990). Honey bee Venom; Antioxidant activity and Interleukin production. Arzneimittel Forschung - Drug Research. vol.40-2(8) p.912-913.

1989

Hadjipetrou-Kourounakis L, Karagounis E, Rekka E, Kourounakis P (1989). Immunosuppression by a novel analgesic-opioid agonist. Scandinavian Journal of Immunology. vol.29 p.449-458.

1987

Chatzipetrou-Kourounaki Lygeri, Yiangou Minas, Kourounakis Panagiotis (1987). Effect of age on the induction of in vitro drug metabolism by pregnenolone 16alpha-carbonitrile (PCN);: Effect οf age and PCN on immune responses. Pharmazie. vol.42 p.677-680.

1984

Kourounakis P, Hadjipetrou-Kourounakis L (1984). Effect of pregnendone-16a-carbonitrile on adjuvant induced disease. Pharmaceutica acta Helvetiae. vol.59 p.348-352.

1983

Hadjipetrou-Kourounakis L, Kourounakis P (1983). Effect of 5-2, 5-dimethyl-phenyl-6-oxa-1-azabicyclo 3,3,0 octane on Adjuvant induced disease. Pharmaceutica acta Helvetiae. vol.58 p.256-258.

1971

Hadjipetrou-Kourounakis L, Kourounakis P (1971). Experimental Arthritis. Acta Microbiologica Hellenica. vol.16 p.215-228.
Kourounakis P, Hadjipetrou-Kourounakis L (1971). Drug Binding to Plasma Proteins (in Greek). Farmakeftikon Deltion. vol.1 p.35.

1970

Hadjipetrou L. P, Lilly M. D, Kourounakis P (1970). Effect of ferricyanide on Escherichia coli. Antonie van Leeuwenhoek. vol.36 p.531-540.
Hadjipetrou-Kourounakis L, Kourounakis P (1970). Biochemical Fuel Cells. (in Greek). Chimica Chronica. vol.35 p.106-110.
Hadjipetrou-Kourounakis L, Kourounakis P (1970). Biochemical Fuel Cells. Chimica Chronica. vol.35 p.106-110.

1976

Kourounakis P, Selye H, Kourounakis L (1976). Effect of Dexamethasone and spironolactone on the in vitro oxidation of Aniline and Hexobarbital in Relation to Age. Proceedings of the 58th Annual Meeting of the Endocrine Society. p.364.

Aggiornato: 2018-01-22